Events
Per Norlén joins Strike Pharma as new CEO
Strike Pharma, (“Strike”) a Swedish biotech with a novel technology for antibody-drug conjugation, has announced the appointment of Dr Per Norlén, MD PhD, as new CEO. Dr Norlén brings more than 20 years of clinical and commercial experience from leading positions within big pharma and biotech.